News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer
Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body.
New screening trial to save thousands of men’s lives from prostate cancer
Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen men for prostate cancer and double the number of lives saved.
ICR researcher wins prestigious clinical science award
Dr Stephen-John Sammut, a Clinician Scientist at the ICR, and Consultant in Medical Oncology at The Royal Marsden, has been awarded the Graham Bull Prize by the Royal College of Physicians for his work in personalised breast cancer medicine.
Scientists uncover promising new treatment strategy for aggressive form of leukaemia
Scientists have uncovered a promising treatment strategy for an aggressive type of leukaemia – through targeting the enzymes that cells normally use to sense and adapt to changing oxygen levels.
Shape-shifting cancer cell discovery reveals two potential drug targets against skin cancer
Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the body and cause a metastatic cancer.
Ride announced in memory of Hairy Biker Dave Myers to support The Institute of Cancer Research
The Institute of Cancer Research, London, is honoured to be a beneficiary of a motorbike ride in tribute to Dave Myers of the Hairy Bikers. The ride will take place on Saturday 8 June 2024.
Scientists find new ways to convert inhibitors into degraders, paving the way for future drug discoveries
Researchers have discovered ways to convert inhibitor-style targeted cancer drugs into small molecules known as degraders, which help destroy cancer-promoting proteins in cells.
Groundbreaking methodological advance will support the design of innovative new cancer drugs
Scientists have successfully used a new imaging technique to determine the structure and interactions of a protein complex that plays a significant part in the initiation and progression of cancer.
Research uncovers how to target ‘sleeping’ breast cancer cells and prevent relapse
Scientists have discovered how breast cancer cells can ‘hibernate’ to avoid treatment and ‘wake up’ years later – causing a relapse that is more difficult to treat.
Cancer charity founder and cancer genetics pioneer honoured at ICR graduation ceremony
The ICR honoured the founder of CRIS Cancer Foundation, Lola Manterola, and cancer genetics researcher, Professor Sir Bruce Ponder, with honorary degrees at their annual graduation and awards ceremony.
Lynch syndrome: First national NHS patient database of genetic condition aims to prevent cancer
A new database of all patients with Lynch syndrome aims to improve treatment and prevention for those at high-risk of cancer.
New technique opens up study of immune response to cancer by releasing precious material locked in old archive cancer samples
Scientists have developed an improved technique for reading the genetic material associated with the body’s immune response to cancer, making it possible to study tissue samples that have been stored in archives for decades.
